These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 38427196

  • 1. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.
    Rodriguez-Vieitez E, Kumar A, Malarte ML, Ioannou K, Rocha FM, Chiotis K.
    Methods Mol Biol; 2024; 2785():195-218. PubMed ID: 38427196
    [Abstract] [Full Text] [Related]

  • 2. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.
    Rodriguez-Vieitez E, Nordberg A.
    Methods Mol Biol; 2018; 1750():231-251. PubMed ID: 29512077
    [Abstract] [Full Text] [Related]

  • 3. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.
    Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A.
    J Nucl Med; 2012 Jan; 53(1):37-46. PubMed ID: 22213821
    [Abstract] [Full Text] [Related]

  • 4. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
    Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Graff C, Wall A, Långström B, Nordberg A.
    Brain; 2016 Mar; 139(Pt 3):922-36. PubMed ID: 26813969
    [Abstract] [Full Text] [Related]

  • 5. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
    Rodriguez-Vieitez E, Ni R, Gulyás B, Tóth M, Häggkvist J, Halldin C, Voytenko L, Marutle A, Nordberg A.
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
    [Abstract] [Full Text] [Related]

  • 6. Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.
    Chatterjee P, Doré V, Pedrini S, Krishnadas N, Thota R, Bourgeat P, Ikonomovic MD, Rainey-Smith SR, Burnham SC, Fowler C, Taddei K, Mulligan R, Ames D, Masters CL, Fripp J, Rowe CC, Martins RN, Villemagne VL, The AIBL Research Group.
    J Alzheimers Dis; 2023 Jun; 92(2):615-628. PubMed ID: 36776057
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease.
    Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Schöll M, Almkvist O, Wall A, Långström B, Nordberg A.
    J Nucl Med; 2016 Jul; 57(7):1071-7. PubMed ID: 26912447
    [Abstract] [Full Text] [Related]

  • 8. Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease.
    Olsen M, Aguilar X, Sehlin D, Fang XT, Antoni G, Erlandsson A, Syvänen S.
    Mol Imaging Biol; 2018 Aug; 20(4):605-614. PubMed ID: 29297157
    [Abstract] [Full Text] [Related]

  • 9. Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography.
    Schöll M, Carter SF, Westman E, Rodriguez-Vieitez E, Almkvist O, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A.
    Sci Rep; 2015 Nov 10; 5():16404. PubMed ID: 26553227
    [Abstract] [Full Text] [Related]

  • 10. Multitracer Approach to Understanding the Complexity of Reactive Astrogliosis in Alzheimer's Brains.
    Fontana IC, Kumar A, Okamura N, Nordberg A.
    ACS Chem Neurosci; 2024 Jan 17; 15(2):328-336. PubMed ID: 38133820
    [Abstract] [Full Text] [Related]

  • 11. [18F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data.
    Ballweg A, Klaus C, Vogler L, Katzdobler S, Wind K, Zatcepin A, Ziegler SI, Secgin B, Eckenweber F, Bohr B, Bernhardt A, Fietzek U, Rauchmann BS, Stoecklein S, Quach S, Beyer L, Scheifele M, Simmet M, Joseph E, Lindner S, Berg I, Koglin N, Mueller A, Stephens AW, Bartenstein P, Tonn JC, Albert NL, Kümpfel T, Kerschensteiner M, Perneczky R, Levin J, Paeger L, Herms J, Brendel M.
    J Neuroinflammation; 2023 Mar 11; 20(1):68. PubMed ID: 36906584
    [Abstract] [Full Text] [Related]

  • 12. In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer's Brain Tissue.
    Ni R, Röjdner J, Voytenko L, Dyrks T, Thiele A, Marutle A, Nordberg A.
    J Alzheimers Dis; 2021 Mar 11; 80(4):1723-1737. PubMed ID: 33749648
    [Abstract] [Full Text] [Related]

  • 13. Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients.
    Choo IL, Carter SF, Schöll ML, Nordberg A.
    Eur J Nucl Med Mol Imaging; 2014 Nov 11; 41(11):2120-6. PubMed ID: 25077930
    [Abstract] [Full Text] [Related]

  • 14. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD.
    Neuroimage Clin; 2014 Nov 11; 4():508-16. PubMed ID: 24818077
    [Abstract] [Full Text] [Related]

  • 15. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease.
    Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A.
    Brain; 2011 Jan 11; 134(Pt 1):301-17. PubMed ID: 21149866
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of 10-minute post-injection 11C-PiB PET and its correlation with 18F-FDG PET in older adults who are cognitively healthy, mildly impaired, or with probable Alzheimer's disease.
    Carneiro CG, Faria DP, Coutinho AM, Ono CR, Duran FLS, da Costa NA, Garcez AT, da Silveira PS, Forlenza OV, Brucki SMD, Nitrini R, Busatto G, Buchpiguel CA.
    Braz J Psychiatry; 2022 Aug 15; 44(5):495-506. PubMed ID: 36420910
    [Abstract] [Full Text] [Related]

  • 17. Imaging of Reactive Astrogliosis by Positron Emission Tomography.
    Harada R, Furumoto S, Kudo Y, Yanai K, Villemagne VL, Okamura N.
    Front Neurosci; 2022 Aug 15; 16():807435. PubMed ID: 35210989
    [Abstract] [Full Text] [Related]

  • 18. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB.
    Neuroimage; 2010 Aug 15; 52(2):488-96. PubMed ID: 20385246
    [Abstract] [Full Text] [Related]

  • 19. Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer's disease with multi-modal PET and plasma GFAP.
    Chiotis K, Johansson C, Rodriguez-Vieitez E, Ashton NJ, Blennow K, Zetterberg H, Graff C, Nordberg A.
    Mol Neurodegener; 2023 Sep 12; 18(1):60. PubMed ID: 37697307
    [Abstract] [Full Text] [Related]

  • 20. ³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain.
    Marutle A, Gillberg PG, Bergfors A, Yu W, Ni R, Nennesmo I, Voytenko L, Nordberg A.
    J Neuroinflammation; 2013 Jul 23; 10():90. PubMed ID: 23880036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.